M&A Deal Summary |
|
|---|---|
| Date | 2021-05-06 |
| Target | Holdbart |
| Sector | E-Commerce |
| Buyer(s) | Summa Equity |
| Deal Type | Buyout (LBO, MBO, MBI) |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 2016 |
| PE ASSETS | 14.0B SEK |
| Size | Middle-Market |
| Type | Sector Agnostic |
Summa Equity is a private equity firm that looks to invest €10 to €50 million per transaction and pursues growing companies with significant business relations in the Nordic region. Summa Equity was formed in 2016 and is headquartered in Stockholm, Sweden.
| DEAL STATS | # |
|---|---|
| Overall | 16 of 25 |
| Sector: E-Commerce M&A | 1 of 1 |
| Type: Buyout (LBO, MBO, MBI) M&A Deals | 7 of 10 |
| Country: Norway M&A | 4 of 6 |
| Year: 2021 M&A | 1 of 5 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-03-25 |
Olink
Uppsala, Sweden Olink provides leading solutions for advanced proteomics research and development, enabling biopharmaceutical companies and leading academic researchers to quickly and efficiently understand diseases at the protein level. Olink's proprietary technology, Proximity Extension Assay (PEA), enables high-throughput protein analysis for the very large installed base of qPCR and next-generation sequencing readout systems on the market. Olink was founded in 2016 and is based in Uppsala, Sweden. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-05-16 |
HyTest
Turku, Finland HyTest produces antibodies and antigens for the IVD industry for use as key components of various laboratory assays and kits. HyTest’s customer base includes a large number of companies that supply IVD equipment, including many of the global leaders in the IVD market. The company is active across the globe, including US, Asia and Europe. HyTest was founded in 1994 and is based in Turku, Finland. |
Sell | €545M |
